Correlation Between Avivagen and Green Cures
Can any of the company-specific risk be diversified away by investing in both Avivagen and Green Cures at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avivagen and Green Cures into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avivagen and Green Cures Botanical, you can compare the effects of market volatilities on Avivagen and Green Cures and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avivagen with a short position of Green Cures. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avivagen and Green Cures.
Diversification Opportunities for Avivagen and Green Cures
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Avivagen and Green is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Avivagen and Green Cures Botanical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Green Cures Botanical and Avivagen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avivagen are associated (or correlated) with Green Cures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Green Cures Botanical has no effect on the direction of Avivagen i.e., Avivagen and Green Cures go up and down completely randomly.
Pair Corralation between Avivagen and Green Cures
If you would invest 0.02 in Green Cures Botanical on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Green Cures Botanical or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Avivagen vs. Green Cures Botanical
Performance |
| Timeline |
| Avivagen |
| Green Cures Botanical |
Avivagen and Green Cures Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Avivagen and Green Cures
The main advantage of trading using opposite Avivagen and Green Cures positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avivagen position performs unexpectedly, Green Cures can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Green Cures will offset losses from the drop in Green Cures' long position.| Avivagen vs. Genomma Lab Internacional | Avivagen vs. City View Green | Avivagen vs. Procyon | Avivagen vs. West Island Brands |
| Green Cures vs. Cann American Corp | Green Cures vs. Rimrock Gold Corp | Green Cures vs. Galexxy Holdings | Green Cures vs. Indoor Harvest Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |